Law360, Los Angeles (March 4, 2014, 4:21 PM EST) -- Sixty percent of Medicare drug plans don't submit data on potential fraud to the Centers for Medicare and Medicaid Services, the U.S. Department of Health and Human Services' Office of Inspector General said Monday, amid separate findings that CMS doesn't follow up on Medicare Advantage insurers' data problems.
Despite past recommendations to require data on fraud and abuse from Medicare Plan D sponsors, CMS made submissions voluntary, HHS Inspector General Daniel Levinson's office said in a report.
"[CMS] cannot assess the efficacy throughout the Part D...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.